| Virus resistance and gene silencing in plants can be induced by simultaneous expression of sense and antisense RNA. | Waterhouse PM, Graham MW, Wang M-B. Proc Natl Acad Sci USA 1998. Nov; 95:13959-64. |
| Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans | Fire A, Xu SQ, Montgomery MK, Kostas SA, Driver SE, Mello CC. Nature 1998. Feb; 391:806-11. |
| Duplexes of 21±nucleotide RNAs mediate RNA interference in cultured mammalian cells | Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Nature 2001. May; 411:494-8. |
| Targeted mRNA degradation by double-stranded RNA in vitro |
Tuschl T, Zamore PD, Lehmann R, Bartel DP, Sharp PA. Genes Dev 1999. 13:3191-7. |
| Expanding small RNA interference | Tuschl T.Nature Biotechnol 2002. May; 20:446-8. |
| Effective expression of small interfering RNA in human cells | Paul CP, Good PD, Winer I, Engelke DR. Nature Biotechnol 2002. May; 20:505-8. |
| The silent treatment: RNAi as a defense against virus infection in mammals. | van Rij RP, Andino R. Trends Biotechnol 2006. Apr; 24(4):186-93. |
| Is RNA interference involved in intrinsic antiviral immunity in mammals? | Cullen BR. Nat Immunol 2006. June; 7(6):563-7. |
| Gene silencing of virus replication by RNA interference. | Miyano-Kurosaki N, Takaku H. Handb Exp Pharmacol 2006. 173:151-71. |
| Exploring the functions of RNA interference pathway proteins: some functions are more RISCy than others? | Jaronczyk K, Carmichael JB, Hobman TC. Biochem J 2005. May;387(Pt 3):561-71. |
| Viral delivery of recombinant short hairpin RNAs. | Davidson BL, Harper SQ. Meth Enzymol 2005. 392:145-73 |
| Paradigms for conditional expression of RNA interference molecules for use against viral targets. | Strayer DS, Feitelson M, Sun B, Matskevich AA. Meth Enzymol 2005;392:227-41 |
| Small RNA asymmetry in RNAi: function in RISC assembly and gene regulation. | Hutvagner G. FEBS Lett 2005 Oct;579(26):5850-7 Cell 2005 Jul;122(1):17-20 |
| RNAi: the nuts and bolts of the RISC machine. | Filipowicz W. Cell 2005 Jul;122(1):17-20 |
| Molecular mechanisms of RNAi: implications for development and disease. | Rao M, Sockanathan S. Birth Defects Res C Embryo Today. 2005 Mar;75(1):28-42 |
| RNAi-mediated pathways in the nucleus. | Matzke MA, Birchler JA. Nat Rev Genet 2005 Jan;6(1):24-35 |
| Dicing and slicing: the core machinery of the RNA interference pathway. | Hammond SM. FEBS Lett 2005 Oct;579(26):5822-9 |
| RNA interference, transposon silencing, and cosuppression in the Caenorhabditis elegans germ line: similarities and differences. | Robert VJ, Vastenhouw NL, Plasterk RH. Cold Spring Harb Symp Quant Biol. 2004;69:397-402 |
| Simple, Robust Strategies for Generating DNA-Directed RNA Interference Constructs | Rice RR, Muirhead AN, Harrison BT, Kassianos AJ, Sedlak PL, Maugeri NJ, Goss PJ, Davey JR, James DE, Graham MW. Meth Enzymol 2005. 392:405-19. |
| The silent treatment: RNAi as a defense against virus infection in mammals. | van Rij RP, Andino R. Trends Biotechnol 2006. Apr;24(4):186-93. |
| RNA-based gene therapy for HIV with lentiviral vector-modified CD34+ cells in patients undergoing transplantation for AIDS-related lymphoma | DiGiusto DL Krishnan A, Li L, Li H, Li S, Rao A, Mi S, Yam P, Stinson S, Kalos M, Alvarnas J, Lacey SF, Yee J-K, Li M, Couture L, Hsu D, Forman SJ, Rossi JJ, Zaia JA. Sci Trans Med 2010. June; 2 Issue 36 36ra43. |
| ßIII-tubulin Is a multifunctional protein involved in drug sensitivity and tumorigenesis in non-small cell lung cancer | McCarroll JA, Gan PP, Liu M, Kavallaris M. Cancer Res 2010 May;70(12):OF1-9 |
| Inhibition of cervical cancer cell growth in vitro and in vivo with dual shRNAs. | Gu W, Payne E, Sun S, Burgess M, McMillan NAJ. Cancer Gene Therapy 2011. 18:219-27 |
| RNAi as a new therapeutic strategy against HCV | Khaliq S, Khaliq SA, Zahur M, Ijaz B, Jahan S, Ansar M, Riazuddin S, Hassan S. Biotech Adv 2010. 28:27-34 |
